BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sun B, Huang Z, Wang B, Yu Y, Lin S, Luo L, Wang Y, Huang Z. Significance of Glypican-3 (GPC3) Expression in Hepatocellular Cancer Diagnosis. Med Sci Monit 2017;23:850-5. [PMID: 28207681 DOI: 10.12659/msm.899198] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 3.6] [Reference Citation Analysis]
Number Citing Articles
1 Shimizu Y, Mizuno S, Fujinami N, Suzuki T, Saito K, Konishi M, Takahashi S, Gotohda N, Tada T, Toyoda H, Kumada T, Miura M, Suto K, Yamaji T, Matsuda T, Endo I, Nakatsura T. Plasma and tumoral glypican-3 levels are correlated in patients with hepatitis C virus-related hepatocellular carcinoma. Cancer Sci 2020;111:334-42. [PMID: 31774932 DOI: 10.1111/cas.14251] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
2 Zhang C, Shi Y, Wu L, Wang C, Liao N, Wang F, Zhao B, Wang Y, Liu X. Far-Red Light Triggered Production of Bispecific T Cell Engagers (BiTEs) from Engineered Cells for Antitumor Application. ACS Synth Biol 2022;11:888-99. [PMID: 35113526 DOI: 10.1021/acssynbio.1c00523] [Reference Citation Analysis]
3 Wang W, Wei C. Advances in the early diagnosis of hepatocellular carcinoma. Genes Dis 2020;7:308-19. [PMID: 32884985 DOI: 10.1016/j.gendis.2020.01.014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
4 许佐明, 浦涧. CTLs相关的免疫疗法在肝癌治疗中的新前景. 世界华人消化杂志 2017; 25(15): 1389-1395 [DOI: 10.11569/wcjd.v25.i15.1389] [Reference Citation Analysis]
5 Abouzed TK, Eldomany EB, Khatab SA, Aldhahrani A, Gouda WM, Elgazzar AM, Soliman MM, Kassab MA, El-Shazly SA, Althobaiti F, Dorghamm DA. The modulatory effect of bee honey against diethyl nitrosamine and carbon tetrachloride instigated hepatocellular carcinoma in Wistar rats. Toxicol Res (Camb) 2021;10:1092-103. [PMID: 34992771 DOI: 10.1093/toxres/tfab094] [Reference Citation Analysis]
6 Zhang W, Fu T, Guo Z, Zhang Y, Zhang L, Su H, Long Y, Ji Z, Yan Y, Shao Z. Serum miR-375 Levels Are Closely Related to Disease Progression from HBV Infection to HBV-Related Hepatocellular Carcinoma. Biomed Res Int 2020;2020:5819385. [PMID: 32382558 DOI: 10.1155/2020/5819385] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 Ostrowska-podhorodecka Z, Ding I, Norouzi M, Mcculloch CA. Impact of Vimentin on Regulation of Cell Signaling and Matrix Remodeling. Front Cell Dev Biol 2022;10:869069. [DOI: 10.3389/fcell.2022.869069] [Reference Citation Analysis]
8 El-Saadany S, El-Demerdash T, Helmy A, Mayah WW, El-Sayed Hussein B, Hassanien M, Elmashad N, Fouad MA, Basha EA. Diagnostic Value of Glypican-3 for Hepatocellular Carcinomas. Asian Pac J Cancer Prev 2018;19:811-7. [PMID: 29582639 DOI: 10.22034/APJCP.2018.19.3.811] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
9 Guo M, Zhang H, Zheng J, Liu Y. Glypican-3: A New Target for Diagnosis and Treatment of Hepatocellular Carcinoma. J Cancer. 2020;11:2008-2021. [PMID: 32127929 DOI: 10.7150/jca.39972] [Cited by in Crossref: 22] [Cited by in F6Publishing: 28] [Article Influence: 11.0] [Reference Citation Analysis]
10 Nallanthighal S, Heiserman JP, Cheon DJ. The Role of the Extracellular Matrix in Cancer Stemness. Front Cell Dev Biol. 2019;7:86. [PMID: 31334229 DOI: 10.3389/fcell.2019.00086] [Cited by in Crossref: 75] [Cited by in F6Publishing: 82] [Article Influence: 25.0] [Reference Citation Analysis]
11 Xia L, Teng Q, Chen Q, Zhang F. Preparation and Characterization of Anti-GPC3 Nanobody Against Hepatocellular Carcinoma. Int J Nanomedicine 2020;15:2197-205. [PMID: 32280214 DOI: 10.2147/IJN.S235058] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Xue G, Lin X, Wu JF, Pei D, Wang DM, Zhang J, Zhang WJ. Identification of key genes of papillary thyroid carcinoma by integrated bioinformatics analysis. Biosci Rep 2020;40:BSR20201555. [PMID: 32766727 DOI: 10.1042/BSR20201555] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
13 Baj J, Bryliński Ł, Woliński F, Granat M, Kostelecka K, Duda P, Flieger J, Teresiński G, Buszewicz G, Furtak-Niczyporuk M, Portincasa P. Biomarkers and Genetic Markers of Hepatocellular Carcinoma and Cholangiocarcinoma-What Do We Already Know. Cancers (Basel) 2022;14:1493. [PMID: 35326644 DOI: 10.3390/cancers14061493] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Huang SL, Wang YM, Wang QY, Feng GG, Wu FQ, Yang LM, Zhang XH, Xin HW. Mechanisms and Clinical Trials of Hepatocellular Carcinoma Immunotherapy. Front Genet 2021;12:691391. [PMID: 34306031 DOI: 10.3389/fgene.2021.691391] [Reference Citation Analysis]
15 Shi H, Huttad LV, Tan M, Liu H, Chua M, Cheng Z, So S. NIR-II imaging of hepatocellular carcinoma based on a humanized anti-GPC3 antibody. RSC Med Chem 2022;13:90-7. [DOI: 10.1039/d1md00313e] [Reference Citation Analysis]
16 Chen F, Zhong Z, Tan HY, Wang N, Feng Y. The Significance of Circulating Tumor Cells in Patients with Hepatocellular Carcinoma: Real-Time Monitoring and Moving Targets for Cancer Therapy. Cancers (Basel) 2020;12:E1734. [PMID: 32610709 DOI: 10.3390/cancers12071734] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
17 Shi X, Chen M, Feng H, Zhou Z, Wu R, Li W, Liang J, Chen J, Li G. Glypican-3 electrochemical aptasensor based on reduced graphene oxide‐chitosan‐ferrocene deposition of platinum–palladium bimetallic nanoparticles. J Appl Electrochem 2021;51:781-94. [DOI: 10.1007/s10800-021-01534-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]